Atea Pharmaceuticals (AVIR) Amortizatization of Intangibles (2022 - 2026)

Atea Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $581000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 66.61% year-over-year to $581000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 62.42% YoY), while the FY2025 annual figure was $4.9 million, down 58.18% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $581000.0, down from $808000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $7.9 million in Q4 2022, with the low at $581000.0 in Q1 2026.
• The 5-year median for Amortizatization of Intangibles is $2.9 million (2024), against an average of $2.9 million.
• The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles grew 12.99% in 2024, then plunged 70.22% in 2025.
• Atea Pharmaceuticals' Amortizatization of Intangibles stood at $7.9 million in 2022, then slumped by 45.21% to $4.3 million in 2023, then tumbled by 37.56% to $2.7 million in 2024, then slumped by 70.22% to $808000.0 in 2025, then dropped by 28.09% to $581000.0 in 2026.
• Business Quant data shows AVIR's Amortizatization of Intangibles at $581000.0 in Q1 2026, $808000.0 in Q4 2025, and $1.1 million in Q3 2025.